Test Price
2,800 AED✅ Home Collection Available
FKBP10 Gene Osteogenesis Imperfecta Type XI Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines
تحليل جين FKBP10 لمرض العظم الزجاجي النوع الحادي عشر (تسلسل الجيل التالي) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي
Executive Summary – ملخص تنفيذي
Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Certified NGS Processing (Cert: INT/EGQ/2509DA/3139).
Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy.
Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation by DHA-licensed genetic counsellors.
Insurance: Direct Billing Verification via WhatsApp +971 54 548 8731.
الملخص التنفيذي بالعربية: اختبار تسلسل جين FKBP10 بتقنية الجيل التالي (NGS) لتشخيص مرض العظم الزجاجي النوع الحادي عشر بدقة تشخيصية 99.9%، معتمد من ISO 9001:2015 ومطابق لإرشادات هيئة الصحة بدبي 2026. نقدم خدمة سحب منزلي عالي الجودة، استشارات جينية هاتفية بعد النتيجة، وفحص مباشر للتغطية التأمينية عبر واتساب. خصوصية بياناتك مكفولة بموجب قانون حماية البيانات الشخصية الإماراتي والمرسوم الاتحادي رقم 41 لسنة 2024.
Overview of the FKBP10 Gene Osteogenesis Imperfecta Type XI NGS Test
This next‑generation sequencing test analyses the entire coding region of the FKBP10 gene to identify pathogenic variants causing osteogenesis imperfecta type XI (OI type XI) – a moderate‑to‑severe bone fragility disorder often associated with congenital contractures, skin hyperextensibility, and progressive skeletal deformity. يُعد هذا الاختبار المعياري الذهبي للتشخيص الجيني الدقيق لمرض العظم الزجاجي من النوع الحادي عشر. Results guide personalised orthopaedic and dermatological management, reproductive risk assessment, and cascade family screening.
| Feature | Our NGS Test (This Package) | Closest Alternative (Sanger Sequencing) |
|---|---|---|
| Diagnostic Precision | 99.9% sensitivity for point mutations and small indels | ~95% sensitivity; large deletions/duplications may be missed |
| Methodology | NGS (Next Generation Sequencing) with CNV analysis | Sanger sequencing of individual amplicons |
| Turnaround Time | 3–4 Weeks | 4–6 Weeks (often as reflex after negative first‑tier) |
| Clinical Utility | Full gene coverage – detects novel and known FKBP10 variants | Targeted analysis limited to known hotspots |
ICD‑10‑CM codes: Q78.0 (Osteogenesis imperfecta), Z15.89 (Genetic susceptibility to other disease), Z84.8 (Family history of other specified conditions). LOINC: 83019-6 (FKBP10 gene targeted mutation analysis).
Physician Insight & Safety Protocol – رؤية الطبيب وبروتوكول الأمان
Dr. Prabhakar Reddy, DHA License No. 61713011: “Although the FKBP10 test provides a definitive molecular diagnosis, it must be interpreted in the full clinical context. A negative result does not exclude other bone fragility syndromes, and I strongly recommend in‑person genetic counselling before proceeding with cascade testing of at‑risk relatives. Never stop prescribed bisphosphonates or calcium/vitamin D supplements without direct medical advice.”
⚠ Do not discontinue any prescribed medication without consulting your doctor.
Exclusion Criteria & Emergency Red Flags
- Patient unable to provide informed consent (or legal guardian for minors, in strict compliance with UAE Child Protection Law).
- Known current febrile illness or acute fracture requiring immediate orthopaedic intervention – sample collection may be deferred.
- Pregnancy is not a contraindication; however, post‑amniocentesis counselling is mandatory if prenatal diagnosis is sought.
Seek emergency care if you experience:
- Sudden, severe bone pain or new deformity.
- Blue‑grey scleral discoloration with visual changes.
- Respiratory distress or chest wall deformity impairing breathing.
- Child with multiple fractures after minimal trauma and suspicion of abuse – ensure proper safeguarding.
* Always call 998 for ambulance in the UAE.
Patient FAQ & Clinical Guidance
1. What is the FKBP10 gene test and who needs it?
The FKBP10 NGS identifies pathogenic variants causing osteogenesis imperfecta type XI and is recommended for individuals with recurrent low‑trauma fractures, progressive bone deformities, or a family history of brittle bone disease refractory to standard therapies.
يُستعمل اختبار جين FKBP10 لتشخيص مرض العظم الزجاجي النوع الحادي عشر عند المرضى الذين يعانون من كسور متكررة أو تشوهات عظمية غير مفسرة.
2. How long will it take to receive my results?
Turnaround time is 3 to 4 weeks from sample receipt at our ISO‑accredited laboratory, enabling timely clinical decision‑making for surgical planning or bisphosphonate therapy initiation.
تظهر النتائج خلال 3 إلى 4 أسابيع من استلام العينة، مما يتيح التدخل الطبي المبكر.
3. Is a home blood collection service available across the UAE?
Yes, our VIP mobile phlebotomy team covers all seven Emirates from 8 AM to 11 PM, collecting blood or FTA card samples under cold‑chain conditions with full ISO 9001:2015 compliance.
نحن نوفر خدمة سحب عينات منزلية متميزة في جميع أنحاء الإمارات من الساعة 8 صباحاً حتى 11 مساءً مع الحفاظ على سلامة العينة.
دعم ثنائي اللغة متاح
التحقق من التغطية التأمينية
Check Insurance Coverage Instantly
Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.
توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.
Available in Arabic, English, Hindi & Urdu
ISMS 27001:2022
ISO Accredited
HIPAA
All reports reviewed by DHA-Certified physicians